secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUIC Worldwide Holdings Ltd. (SUIC)
CIK:        0001394108
Form:       8-K/A
Filed at:   2026-08-31T21:17:35+00:00
Accession:  0001477932-26-005334
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.01, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SUIC Worldwide acquires 51% of Taiwan medical-device firm Vision Renu for 30M shares
--------------------------------------------------------------------------------

- SUIC issued 30M shares (35% fully diluted) to acquire 51% of Vision Renu; implied enterprise value $50M based on $0.85/share.
- New leadership: Chen King Te named Chairman/CEO, Kho Jean Jean CFO, Dongsheng Zou director; Lo, Wang, Tan resigned.
- Vision Renu products: presbyopia laser (FDA approval pending) and TMS depression device (Taiwan-approved); 150-unit 2026 orders.
- Pro forma 2025: combined revenue $163K, net loss attributable to SUIC $341K, EPS -$0.0082; goodwill $47.98M recorded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394108/000147793226005334/0001477932-26-005334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394108/000147793226005334/suic_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-005334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer